ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

リコンビナントタンパク質

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
GD5-H5269
製品名称
Human GDF-15 / MIC-1 Protein, Fc Tag (MALS verified)
タンパク質名
GDF-15
Species
Human
HOST
HEK293
100ug: 98000円
お問い合わせ
1mg: 711200円
お問い合わせ

Overview

Synonyms -
Characteristics This protein carries a human IgG1 Fc tag at the N-terminus. The protein has a calculated MW of 38.8 kDa. As a result of glycosylation, the protein migrates as 45-55 kDa under reducing (R) condition, and 70-90 kDa under non-reducing (NR) condition (SDS-PAGE).
Endotoxin Level 1.0 EU per μg
Purity 95%
Description Growth Differentiation Factor 15 (GDF-15), also called Macrophage Inhibitory Cytokine 1 (MIC-1). Expression of MIC-1 mRNA in monocytoid cells is up-regulated by a variety of stimuli associated with activation, including interleukin 1β, tumor necrosis factor α (TNF-α), interleukin 2, and macrophage colony-stimulating factor but not interferon γ, or lipopolysaccharide (LPS). It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in normal and pathological condition. GDF-15 increases during tissue injury and inflammatory states and is associated with cardiometabolic risk. Increased GDF-15 levels are associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, obesity, insulin resistance, diabetes, and chronic kidney diseases in diabetes. Increased GDF-15 level is linked with the progression and prognosis of the disease condition.
Reference -
URL https://www.acrobiosystems.com/P4373-Human-GDF-15--MIC-1-Protein-Fc-Tag-%28MALS-verified%29.html

お問い合わせリスト(-)

お問い合わせフォーム